The decision is the first UPC injunction in open court, and could have far-reaching consequences for NanoString in the EU.
The big pharma firm must “specifically describe” its awareness of Moderna's work in the mRNA COVID-19 vaccine sphere before the end of the month.
Technology is continuing to transform women’s healthcare and female inventors are driving the change—but more needs to be done to ensure they secure IP rights.
Although UK research universities were going strong after Horizon funding was pulled, it was not a sustainable path had the scheme not been reinstated, finds Sarah Speight.
Examining a series of case studies, Takanori Abe of Abe & Partners provides an overview of lifecycle management failures and successes in regimen patents.
The spatial biology firm will appeal the Unified Patent Court’s preliminary injunction | NanoString accuses 10x of ‘misusing non-final court rulings…to eliminate competition in the spatial transcriptomics market’.